Nicotine has implications in different tumors types. Expert's eye making a literature analysis

Journal of B.U.ON.

Volumn 16, Issue 2, 2011, Pages 210-214

  Koukourakis, Georgios ^a   Zacharias, G ^b  

^a Saint Savvas Anticancer Institute of Athens   (Greece)

^b General Hospital of Corinth   (Greece)

Author keywords

Lung cancer; Nicotine; Oral cancer; Smoke; Tobacco; Urinary tract cancer

Indexed keywords

CADMIUM; CIGARETTE SMOKE; LEAD; NICOTINE;

BLADDER CANCER; BLOOD LEVEL; CANCER MORTALITY; CARCINOGENESIS; CIGARETTE SMOKING; GLOMERULAR DYSFUNCTION; HUMAN; KIDNEY CARCINOMA; LARGE CELL CARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; MOUTH MUCOSA; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSITIONAL BLADDER CANCER; URINARY TRACT CANCER;

HUMANS; NEOPLASMS; NICOTINE; NICOTINIC AGONISTS; PROGNOSIS; SMOKING;

EID: 79960250700     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. WHO. Tobacco or health: a global status report. Geneva: World Health Organization, 1997, pp 1-48.
2. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003; 48: 1185-1191; discussion 1191-1193.
3. Available from http://www.who.int/tobacco/about/en/
4. Available from http://www.emro.who.int/Publications/HealthEdReligion/ Smoking/QA.htm
5. Lindell G, Farnebo LO, Chen D et al. Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol 1993; 28: 487-494. (Pubitemid 23172474)
6. Mansvelder HD, De Rover M, McGehee DS, Brussaard AB. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 2003; 480: 117-123. (Pubitemid 37410364)
7. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004; 308: 66-72.
8. Christiani DC. Smoking and the molecular epidemiology of lung cancer. Clin Chest Med 2000; 21: 87-93. (Pubitemid 30183774)
9. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950; 2: 739-748.
10. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. A study of six hundred and eighty-four proved cases. JAMA 1950; 143: 319-326.
11. US Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public health service. Public Health Service Publication no. 1103, 1964.
12. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 2001; 14: 767-790.
13. Montesano R, Hall J. Environmental causes of human cancers. Eur J Cancer 2001; 37: 67-87.
14. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med 2002; 252: 206-224.
15. Newcomb PA, Carbone PP. The health consequences of smoking. Cancer Med Clin North Am 1992; 76: 305-331.
16. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
17. Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 2002; 23: 1-25. (Pubitemid 34205605)
18. La Vecchia C, Franceschi S, Levi F. Epidemiological research on cancer with a focus on Europe. Eur J Cancer Prev 2003; 12: 5-14. (Pubitemid 36233017)
19. Wingo PA, Ries LA, Giovino GA et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999; 91: 675-690.
20. Peto R, Darby S, Deo H et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323-329.
21. Erren TC, Jacobsen M, Piekarski C. Synergy between asbestos and smoking on lung cancer risks. Epidemiology 1999; 10: 405-411. (Pubitemid 29288239)
22. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2: 1525-1536.
23. Capewell S, Sankaran R, Lamb D et al. Lung cancer in lifelong non-smokers. Edinburgh Lung Cancer Group. Thorax 1991; 46: 565-568.
24. Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women. Cancer Control 1996; 7: 366-376. (Pubitemid 26163888)
25. Camoirano A, Bagnasco M, Bennicelli C et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits. Cancer Epidemiol Biomarkers Prev 2001; 10: 775-783.
26. Boffetta P, Pershagen G, Jockei KH et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 1999; 91: 697-701. (Pubitemid 29234563)
27. Richardson TL. African-American smokers and cancers of the lung and of the upper respiratory and digestive tracts. Is menthol part of the puzzle? West J Med 1997; 166: 189-194. (Pubitemid 27188357)
28. Thun MJ, Lally CA, Flannery JT et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997; 89: 1580-1586. (Pubitemid 27479717)
29. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med 2001; 344: 1323-1326. (Pubitemid 32372968)
30. Jordan RC, Daley T. Oral squamous cell carcinoma: new insight. Can Dent Assoc 1997; 63: 517-518, 521-525.
31. Holleb AI, Fink DJ, Murphy GP. Textbook of Clinical Oncology. American Cancer Society, 1991.
32. Chen CL, Chi CW, Liu TY. Hydroxyl radical formation and oxidative DNA damage induced by areca quid in vivo. J Toxicol Environ Health 2002; 65: 327-336.
33. Klein I, Nagler RM, Tofler R, Van der Vliet A, Reznick AZ. Effect of cigarette smoke on oral peroxidase activity in human saliva: role of hydrogen cyanide. Free Radic Biol Med 2003; 35: 1448-1452. (Pubitemid 37452469)
34. Dautzenberg, B. Tobacco related disease. Rev Prat 2004; 54: 1877-1882. (Pubitemid 39563583)
35. Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Family history and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2001; 10: 1001-1004. (Pubitemid 32844909)
36. Weisburger JH. Worldwide prevention of cancer and other chronic diseases based on knowledge of mechanisms. Mutat Res 1998; 402: 331-337. (Pubitemid 28440290)
37. Frost MA, Coates AS. Plasma carcinoembryonic antigen in an Australian hospital population. Med J Aust 1976; 1: 950-953.
38. Denton TT, Zhang X, Cashman JR. Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol 2004; 67: 751-756. (Pubitemid 38125259)
39. Silverman D, Devesa S, Moore L et al. Bladder cancer. In: Schottenfeld D, Fraumeni J (Eds): Cancer epidemiology and prevention. Oxford University Press, 2006.
40. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007; 25: 285-295.
41. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation Into Cancer and Nutrition. Int J Cancer 2006; 119: 2412-2416. (Pubitemid 44546965)
42. Pitard A, Brennan P, Clavel J et al. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control 2001; 12: 551-556. (Pubitemid 32735127)
43. Samanic C, Kogevinas M, Dosemeci M et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006; 15: 1348-1354. (Pubitemid 44125293)